Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination

Vaccine

Volumn 31, Issue 2, 2013, Pages 387-393

  Prelog, M ^a,b   Almanzar, G ^a   Rieber, N ^c,d   Ottensmeier, B ^a   Zlamy, M ^b   Liese, J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acellular pertussis vaccine; Antibody; Avidity; Pertussis; Whole cell pertussis vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; WHOLE CELL PERTUSSIS VACCINE;

ADOLESCENT; ANTIGEN BINDING; ARTICLE; CHILD; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PERTUSSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADHESINS, BACTERIAL; ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; BORDETELLA PERTUSSIS; CHILD; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; MALE; PERTUSSIS TOXIN; PERTUSSIS VACCINE; VACCINATION; VIRULENCE FACTORS, BORDETELLA;

EID: 84871382554     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.105     Document Type: Article

References (32)

1. Heininger U. Update on pertussis in children. Expert Rev Anti Infect Ther 2010, 8:163-173.
2. Heininger U., Cherry J.D. Pertussis immunization in adolescents and adults-Bordetella pertussis epidemiology should guide vaccination recommendations. Expert Opin Biol Ther 2006, 6:685-697.
3. Bamberger E.S., Srugo I. What is new in pertussis?. Eur J Pediatr 2008, 167:133-139.
4. Zepp F., Heininger U., Mertsola J., Bernatowska E., Guiso N., Roorf J., et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011, 11:557-570.
5. Zhang L., Prietsch S.O., Axelsson I., Halperin S.A. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2011, 3:CD001478.
6. Rieber N., Graf A., Belohradsky B.H., Hartl D., Urschel S., Riffelmann M., et al. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 2008, 26:6929-6935.
7. Rieber N., Graf A., Hartl D., Urschel S., Belohradsky B.H., Liese J., et al. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response. PLoS ONE 2011, 6:e17271.
8. Hofmann J., Lierbt U.G. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women. J Virol Methods 2005, 130:66-71.
9. Goodnow C.C., Vinuesa C.G., Randall K.L., Mackay F., Brink R. Control systems and decision making for antibody production. Nature Immunol 2010, 11:681-688.
10. Goldblatt D., Vaz A.R., Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998, 177(4):1112-1115.
11. Ahmed R., Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996, 272:54-60.
12. Hendrikx L.H., Öztürk K., de Rond L.G.H., Veenhoven R.H., Sanders E.A.M., Berbers G.A.M., et al. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins. Vaccine 2011, 29:1431-1437.
13. Liese J.G., Rieber N., Malzer T., Ocak M., Johnson D.R., Decker M.D., et al. Munich vaccine study group. Reactogenicity of tetanus, diphtheria, 5-component acellular pertussis vaccine administered as a sixth consecutive acellular pertussis vaccine dose to adolescents. Pediatr Infect Dis J 2010, 29:1067-1071.
14. Riffelmann M., Thiel K., Schmetz J., Wirsing von König C.H. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010, 48:4459-4463.
15. Guiso N., Berbers G., Fry N.K., He Q., Riffelmann M., Wirsing von König C.H., et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2010, 30:307-312.
16. Melker de H.E., VErsteegh F.G.A., Conyn van Spaendonck M.A.E., Elvers L.H., Berbers G.A.M., Zee van der A., et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against Pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000, 38:800-806.
17. Wirsing von König C.H., Gounis D., Laukamp S., Bogaerts H., Schmitt H.J. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur J Clin Microbiol Infect Dis 1999, 18:341-345.
18. Almanzar G, Ottensmeier B, Liese J, Prelog M. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate. J Immunol Meth 2012; in press.
19. Kneitz R.H., Schubert J., Tollmann F., Zens W., Hedman K., Weissbrich B., et al. A new method for determination of varicella-zoster virus immunoglobulin G avidty in serum and cerebrospinal fluid. BMC Infect Dis 2004, 4:1-11.
20. Baker J.D., Halperin S.A., Edwards K., Miller B., Decker M., Stephens D., et al. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J Pediatr 1992, 121:523-527.
21. Giuliano M., Mastrantonio P., Giammanco A., Piscitelli A., SAlmaso S., Wassilak S.G.F., et al. Antibody response and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 1998, 132:983-988.
22. Storsaeter J., Hallander H.O., Gustafsson L., Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998, 16:1907-1916.
23. Tomoda T., Ogura H., Kurashige T. Immune response to Bordetella pertussis infection and vaccination. J Infect Dis 1991, 163:559-563.
24. Van Damme P., Burgess M. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine 2004, 22:305-308.
25. Ridings J., Nocholson I.C., Goldsworthy W., Haslam R., Roberton D.M., Zola H., et al. Somatic hypermutation of immunoglobulin genes in human neonates. Clin Exp Immunol 1997, 108:366-374.
26. Ridings J., Dinan L., Williams R., Roberton D., Zola H. Somatic mutation of immunoglobulin V(H)6 genes in human infants. Clin Exp Immunol 1998, 114:33-39.
27. Eisen H.N., Siskind G.W. Variations in affinities of antibodies during the immune response. Biochemistry 1964, 3:996-1008.
28. Pichichero M.E., Voloshen T., Zajac D., Passador S. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants. J Infect Dis 1999, 180:1390-1393.
29. Hendrikx L.H., Berbers G.A.M., Veenhoven R.H., Sanders E.A.M., Buisman A.M. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 2009, 27:6530-6536.
30. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., et al. Competence and competition: the challenge of becoming a long-lived plasme cell. Nat Rev Immunol 2006, 6:741-750.
31. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915.
32. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002, 298:2199-2202.